| Literature DB >> 34128097 |
Barbara Schürch1, Gwendolin Manegold-Brauer2, Heidrun Schönberger2, Johanna Büchel2, Olav Lapaire2, Annkathrin Butenschön2, Evelyn A Huhn2, Dorothy Huang2, Katrina S Evers3, Alexandra Goischke3, Martina Frech-Dörfler4, Christoph Rudin5.
Abstract
BACKGROUND: Fetal ultrasound organ screening has become a standard of care in most high-income countries. This has resulted in increased detection of congenital abnormalities, which may lead to major uncertainty and anxiety in expectant parents, even though many of them are of minor relevance. In order to optimize prenatal counselling, we introduced an interdisciplinary approach for all pregnant women referred to our center by private obstetricians for a co-assessment of suspected relevant fetal abnormalities of the kidney or urinary tract, involving both experienced prenatal ultrasound specialists and a pediatric nephrologist or urologist.Entities:
Keywords: AUDAKUT; CAKUT; Fetal ultrasound; Hydronephrosis; Kidney malformation; Urinary tract anomaly
Mesh:
Year: 2021 PMID: 34128097 PMCID: PMC8599352 DOI: 10.1007/s00467-021-05139-z
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714
Fig. 1Number of patients included in/excluded from the study and reasons for exclusion
Fig. 2Principles of investigations and follow-up of neonates with fetal/congenital hydronephrosis
Patients’ main characteristics (174 live borns)
| Figures | Number of patients (percentage) | |||||
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 105 (60.0%) | |||||
| Female | 69 (39.4%) | |||||
| Not known (IUFD) | 1 (0.6%) | |||||
| Male-to-female ratio | 1.52:1 | |||||
| Duration of pregnancy (weeks of gestation) | ||||||
| Term (≥ 38) | 162 (93.1%) | |||||
| Preterm (< 38) | 12 (6.9%) | |||||
| 35–37 | 10 | |||||
| 29–34 | 1 | |||||
| < 29 | 1 | |||||
| Birth weight | ||||||
| Mean birth weight (range) | 3379 ± 583 g (1490–4790) | |||||
| Maternal characteristics | ||||||
| Maternal age (range) | 32.4 ± 5.2 years (20–47) | |||||
| Parity | ||||||
| P0 | 93 (53.1%) | |||||
| P1 | 61 (34.9%) | |||||
| ≥ P2 | 21 (12.0%) | |||||
| Positive family medical history for CAKUTa | ||||||
| Overall positive family medical history for CAKUT | 50 (30.1%) | |||||
| Identical to the anomaly diagnosed in the study subject | 10 (6.0%) | |||||
| Different to the anomaly diagnosed in the study subject | 40 (24.1%) | |||||
| Associated extrarenal anomaliesb | ||||||
| No associated anomaly | 118 (75.6%) | |||||
| Single associated anomaly | 27 (17.3%) | |||||
| Several associated anomalies | 11 (7.1%) | |||||
aDetails about family medical history for CAKUT, see online Supplementary Information 1
bDetails about associated extrarenal anomalies, see online Supplementary Information 2
Outcome of hydronephrosis and final diagnoses in patients of group 1 (n = 97)
| Final etiological diagnosis | Outcome of hydronephrosis/diagnosis | Number of patients ( | Percentage | ||||
|---|---|---|---|---|---|---|---|
| No | 78 | 80.4% | |||||
| Complete resolution of hydronephrosis | 39 | 40.2% | |||||
| • without associated pathologies | 38 | ||||||
| • with associated ADPKD | 1 | ||||||
| Persistent hydronephrosis | 39 | 40.2% | |||||
| • isolated hydronephrosis | 33 | ||||||
| • isolated hydroureter | 1 | ||||||
| • hydronephrosis and hydroureter | 5 | ||||||
| Yes | 19 | 19.6% | |||||
| PUJO | 9 | ||||||
| • isolated | 7 | ||||||
| • + VUJO | 1 | ||||||
| • + cystic dysplastic kidney | 1 | ||||||
| Duplex kidney | 2 | ||||||
| • isolated | 0 | ||||||
| • + ureterocele | 1 | ||||||
| • + VUR | 1 | ||||||
| Urethral valves | 3 | ||||||
| • isolated | 1 | ||||||
| • + VUR | 1 | ||||||
| • + VUR + PUJO | 1 | ||||||
| VUR | 2 | ||||||
| Adult ureterocele | 1 | ||||||
| VUJO | 1 | ||||||
| Ureteral stenosis | 1 | ||||||
ADPKD autosomal dominant polycystic kidney disease, VUR vesico-ureteral reflux, VUJO vesico-ureteric junction obstruction, PUJO pelviureteric junction obstruction
Fig. 3Specific final diagnosis and need for intervention at the end of follow-up in relation to the degree of the intrauterine hydronephrosis (per patient analysis of group 1) (for the per kidney unit analysis, see Supplementary Information 3). aWithout etiological diagnosis. LG hydronephrosis low-grade hydronephrosis (grades I and II according to the grading system of Beetz et al. [15]), HG hydronephrosis high-grade hydronephrosis (grades III and IV according to the grading system of Beetz et al. [15])
Final diagnoses and concordance with intrauterine diagnoses in patients of group 2 (n = 78) (for details see electronic Supplementary Information 4)
| Concordancea | Final diagnosis | Number of patients (n=78) and percentage | ||
|---|---|---|---|---|
| Yes/Given | 63 | 80.8% | ||
| ADPKD | 1 | |||
| Agenesis | 11 | |||
| Ectopy | 11 | |||
| Multicystic dysplastic kidney | 15 | |||
| Duplex kidney | 16 | |||
| PUJO | 1 | |||
| Urethral valves | 4 | |||
| VUR | 2 | |||
| Cystic dysplastic kidney | 1 | |||
| Ureterocele | 1 | |||
| Yes/Partial | 4 | 5.1% | ||
| Ureterocele | 1 | |||
| Duplex kidney | 2 | |||
| Multicystic dysplastic kidney | 1 | |||
| No/Different Pathologies | 1 | 1.3% | ||
| VUR | 1 | |||
| No/False Positives | 10 | 12.8% | ||
| No pathology | 7 | |||
| Hydronephrosis | 2 | |||
| Hydroureter | 1 | |||
ADPKD autosomal dominant polycystic kidney disease, PUJO pelviureteric junction obstruction, VUR vesico-ureteral reflux
aFor definitions see “Methods” section